Philippe Le Bouteiller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Philippe Le Bouteiller has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Julie Tabiasco
CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France
5 shared publications - Armand Bensussan
Université de Paris; INSERM U976, HIPI Unit, Institut de Recherche Saint-Louis, Paris, France
4 shared publications Maryse Aguerre-Girr
4 shared publications- Jérôme Giustiniani
Inst Mondor Rech Biomed, INSERM, U955, Team Ortonne Neurofibromatosis & lymphoma oncogene, Creteil, France
3 shared publications - Nabila Jabrane-Ferrat
University of Toulouse, INSERM, CNRS, Infinity – Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France
3 shared publications Alain Berrebi
2 shared publications
Latest Publications
- 22 February 2021
- Published by H1 Connect
Faculty Opinions recommendation of Uterine natural killer cell heterogeneity: lessons from mouse models.
The functional importance of decidual natural killer (dNK) cells in early, healthy human pregnancy as well as in virally infected placenta has been thoroughly explored {1-6}. Identification of the major subtypes of human dNK phenotype, i.e. non-cytotoxic CD56bright, CD16neg, CD160neg, and CD9+, has been established. In contrast, human peripheral blood (PB)-NK cells exhibit a different phenotype, i.e. CD56dim, CD16+, CD160+, and CD9neg.cytotoxic phenotype {6,7}. Human dNK functions have been explored using ex vivo, purified placental/stromal trophoblasts {3,8}. Important results have been obtained demonstrating that dNK cells can become cytotoxic to hCMV- or human immunodeficiency virus (HIV)-infected autologous fibroblast/stromal decidual cells {2,5,9,10,11}. Although both hemochorial human and mouse placentas share many features, they differ in ways that affect immunity. The present report emphasizes the importance of mouse animal models providing further evidence of the functionality of human NK cells. Mouse models are crucial for further investigations that would define the function of uterine NK subtypes. Despite species-specific structural anatomic differences between mouse and human pregnancies, functional similarities and differences between mouse and human NK cells are discussed in this report bringing new concepts. In both species, decidualization is accompanied by vascular arterial remodeling {1,7} and dNK cell accumulation {11}. According to the authors of this review, both human and mouse placental pathologies support that uterine vascular remodeling defects are associated with preeclampsia and fetal growth retardation. Thus, using mouse models is likely to promote scientific advances in human dNK biology in healthy as well as in infected pregnancy.
- 22 February 2021
- Published by H1 Connect
Faculty Opinions recommendation of Uterine natural killer cell heterogeneity: lessons from mouse models.
The functional importance of decidual natural killer (dNK) cells in early, healthy human pregnancy as well as in virally infected placenta has been thoroughly explored {1-6}. Identification of the major subtypes of human dNK phenotype, i.e. non-cytotoxic CD56bright, CD16neg, CD160neg, and CD9+, has been established. In contrast, human peripheral blood (PB)-NK cells exhibit a different phenotype, i.e. CD56dim, CD16+, CD160+, and CD9neg.cytotoxic phenotype {6,7}. Human dNK functions have been explored using ex vivo, purified placental/stromal trophoblasts {3,8}. Important results have been obtained demonstrating that dNK cells can become cytotoxic to hCMV- or human immunodeficiency virus (HIV)-infected autologous fibroblast/stromal decidual cells {2,5,9,10,11}. Although both hemochorial human and mouse placentas share many features, they differ in ways that affect immunity. The present report emphasizes the importance of mouse animal models providing further evidence of the functionality of human NK cells. Mouse models are crucial for further investigations that would define the function of uterine NK subtypes. Despite species-specific structural anatomic differences between mouse and human pregnancies, functional similarities and differences between mouse and human NK cells are discussed in this report bringing new concepts. In both species, decidualization is accompanied by vascular arterial remodeling {1,7} and dNK cell accumulation {11}. According to the authors of this review, both human and mouse placental pathologies support that uterine vascular remodeling defects are associated with preeclampsia and fetal growth retardation. Thus, using mouse models is likely to promote scientific advances in human dNK biology in healthy as well as in infected pregnancy.
- 22 October 2020
- Published by H1 Connect
- Vol. 182 (5)
Faculty Opinions recommendation of Decidual NK cells transfer granulysin to selectively kill bacteria in trophoblasts.
Maternal decidual NK (dNK) cells promote placentation, but how they protect against placental infection while maintaining fetal tolerance is unclear. Here we show that human dNK cells highly express the antimicrobial peptide granulysin (GNLY) and selectively transfer it via nanotubes to extravillous trophoblasts to kill intracellular Listeria monocytogenes (Lm) without killing the trophoblast. Transfer of GNLY, but not other cell death-inducing cytotoxic granule proteins, strongly inhibits Lm in human placental cultures and in mouse and human trophoblast cell lines. Placental and fetal Lm loads are lower and pregnancy success is greatly improved in pregnant Lm-infected GNLY-transgenic mice than in wild-type mice that lack GNLY. This immune defense is not restricted to pregnancy; peripheral NK (pNK) cells also transfer GNLY to kill bacteria in macrophages and dendritic cells without killing the host cell. Nanotube transfer of GNLY allows dNK to protect against infection while leaving the maternal-fetal barrier intact. Copyright © 2020 Elsevier Inc. All rights reserved.
- 22 October 2020
- Published by H1 Connect
- Vol. 182 (5)
Faculty Opinions recommendation of Decidual NK cells transfer granulysin to selectively kill bacteria in trophoblasts.
Maternal decidual NK (dNK) cells promote placentation, but how they protect against placental infection while maintaining fetal tolerance is unclear. Here we show that human dNK cells highly express the antimicrobial peptide granulysin (GNLY) and selectively transfer it via nanotubes to extravillous trophoblasts to kill intracellular Listeria monocytogenes (Lm) without killing the trophoblast. Transfer of GNLY, but not other cell death-inducing cytotoxic granule proteins, strongly inhibits Lm in human placental cultures and in mouse and human trophoblast cell lines. Placental and fetal Lm loads are lower and pregnancy success is greatly improved in pregnant Lm-infected GNLY-transgenic mice than in wild-type mice that lack GNLY. This immune defense is not restricted to pregnancy; peripheral NK (pNK) cells also transfer GNLY to kill bacteria in macrophages and dendritic cells without killing the host cell. Nanotube transfer of GNLY allows dNK to protect against infection while leaving the maternal-fetal barrier intact. Copyright © 2020 Elsevier Inc. All rights reserved.
- Open Access
- 25 July 2017
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 1216
Up-and-down immunity of pregnancy in humans
One part of the human placenta in early pregnancy is particularly important for local immunity: the decidua basalis, which is transformed endometrium located at the site of embryo implantation. This placental bed tissue contains both maternal uterine immune cells, including decidual natural killer (NK) cells, the dominant leukocyte population exhibiting a unique phenotype, and fetal extravillous trophoblast which comes into direct contact with maternal decidual cells. To establish a successful placental development and healthy pregnancy outcome, the maternal immune system must tolerate paternal antigens expressed by trophoblast cells yet remain efficient for clearing any local pathogen infection. This review deals mainly with decidual NK cells. A key element, among others, to achieve such dual functions is the direct interaction between activating and inhibitory receptors expressed by decidual NK cells and their specific ligands presented by trophoblast or other decidual cells. Depending whether maternal decidual cells and trophoblast are infected by viruses, the balance between activating and inhibitory receptor signals mediated by decidual NK cell–trophoblast cross-talk results in tolerance (healthy pregnancy) or specific killing (pathogen-infected cells).
- 25 July 2017
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 1216
Open AccessUp-and-down immunity of pregnancy in humans
One part of the human placenta in early pregnancy is particularly important for local immunity: the decidua basalis, which is transformed endometrium located at the site of embryo implantation. This placental bed tissue contains both maternal uterine immune cells, including decidual natural killer (NK) cells, the dominant leukocyte population exhibiting a unique phenotype, and fetal extravillous trophoblast which comes into direct contact with maternal decidual cells. To establish a successful placental development and healthy pregnancy outcome, the maternal immune system must tolerate paternal antigens expressed by trophoblast cells yet remain efficient for clearing any local pathogen infection. This review deals mainly with decidual NK cells. A key element, among others, to achieve such dual functions is the direct interaction between activating and inhibitory receptors expressed by decidual NK cells and their specific ligands presented by trophoblast or other decidual cells. Depending whether maternal decidual cells and trophoblast are infected by viruses, the balance between activating and inhibitory receptor signals mediated by decidual NK cell–trophoblast cross-talk results in tolerance (healthy pregnancy) or specific killing (pathogen-infected cells).
- Open Access
- 21 January 2016
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 14 (1) , 1-14
Interleukin-17-producing decidual CD4+ T cells are not deleterious for human pregnancy when they also produce interleukin-4
Trophoblast expressing paternal HLA-C antigens resemble a semiallograft, and could be rejected by maternal CD4+ T lymphocytes. We examined the possible role in human pregnancy of Th17 cells, known to be involved in allograft rejection and reported for this reason to be responsible for miscarriages. We also studied Th17/Th1 and Th17/Th2 cells never investigated before. We defined for the first time the role of different Th17 subpopulations at the embryo implantation site and the role of HLA-G5, produced by the trophoblast/embryo, on Th17 cell differentiation. Cytokine production by CD4+ purified T cell and T clones from decidua of normal pregnancy, unexplained recurrent abortion, and ectopic pregnancy at both embryo implantation site and distant from that site were analyzed for protein and mRNA production. Antigen-specific T cell lines were derived in the presence and in the absence of HLA-G5. We found an associated spontaneous production of IL-17A, IL-17F and IL-4 along with expression of CD161, CCR8 and CCR4 (Th2- and Th17-type markers) in fresh decidua CD4+ T cells during successful pregnancy. There was a prevalence of Th17/Th2 cells (producing IL-17A, IL-17F, IL-22 and IL-4) in the decidua of successful pregnancy, but the exclusive presence of Th17 (producing IL-17A, IL-17F, IL-22) and Th17/Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ) cells was found in the decidua of unexplained recurrent abortion. More importantly, we observed that Th17/Th2 cells were exclusively present at the embryo implantation site during tubal ectopic pregnancy, and that IL-4, GATA-3, IL-17A, ROR-C mRNA levels increased in tubal biopsies taken from embryo implantation sites, whereas Th17, Th17/Th1 and Th1 cells are exclusively present apart from implantation sites. Moreover, soluble HLA-G5 mediates the development of Th17/Th2 cells by increasing IL-4, IL-17A and IL-17F protein and mRNA production of CD4+ T helper cells. No pathogenic role of decidual Th17 cells during pregnancy was observed. Indeed, a beneficial role for these cells was observed when they also produced IL-4. HLA-G5 could be the key feature of the uterine microenvironment responsible for the development of Th17/Th2 cells, which seem to be crucial for successful embryo implantation.
- 21 January 2016
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 14 (1) , 1-14
Open AccessInterleukin-17-producing decidual CD4+ T cells are not deleterious for human pregnancy when they also produce interleukin-4
Trophoblast expressing paternal HLA-C antigens resemble a semiallograft, and could be rejected by maternal CD4+ T lymphocytes. We examined the possible role in human pregnancy of Th17 cells, known to be involved in allograft rejection and reported for this reason to be responsible for miscarriages. We also studied Th17/Th1 and Th17/Th2 cells never investigated before. We defined for the first time the role of different Th17 subpopulations at the embryo implantation site and the role of HLA-G5, produced by the trophoblast/embryo, on Th17 cell differentiation. Cytokine production by CD4+ purified T cell and T clones from decidua of normal pregnancy, unexplained recurrent abortion, and ectopic pregnancy at both embryo implantation site and distant from that site were analyzed for protein and mRNA production. Antigen-specific T cell lines were derived in the presence and in the absence of HLA-G5. We found an associated spontaneous production of IL-17A, IL-17F and IL-4 along with expression of CD161, CCR8 and CCR4 (Th2- and Th17-type markers) in fresh decidua CD4+ T cells during successful pregnancy. There was a prevalence of Th17/Th2 cells (producing IL-17A, IL-17F, IL-22 and IL-4) in the decidua of successful pregnancy, but the exclusive presence of Th17 (producing IL-17A, IL-17F, IL-22) and Th17/Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ) cells was found in the decidua of unexplained recurrent abortion. More importantly, we observed that Th17/Th2 cells were exclusively present at the embryo implantation site during tubal ectopic pregnancy, and that IL-4, GATA-3, IL-17A, ROR-C mRNA levels increased in tubal biopsies taken from embryo implantation sites, whereas Th17, Th17/Th1 and Th1 cells are exclusively present apart from implantation sites. Moreover, soluble HLA-G5 mediates the development of Th17/Th2 cells by increasing IL-4, IL-17A and IL-17F protein and mRNA production of CD4+ T helper cells. No pathogenic role of decidual Th17 cells during pregnancy was observed. Indeed, a beneficial role for these cells was observed when they also produced IL-4. HLA-G5 could be the key feature of the uterine microenvironment responsible for the development of Th17/Th2 cells, which seem to be crucial for successful embryo implantation.
- Open Access
- 10 June 2015
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 13 (1) , 1-5
T helper cell mediated-tolerance towards fetal allograft in successful pregnancy
Trophoblast HLA-C antigens from paternal origins, which liken the trophoblast to a semiallograft, could be presented by the maternal APCs to the specific maternal CD4+ T helper cells, which could release various cytokines in response to these alloantigens. On the basis of the cytokines produced, these cells can be classified in Th1, Th2 and Th17 cells. Th1 and Th17 cells, known to be responsible for acute allograft rejection, could be involved in miscarriage and Th2 cells together with regulatory CD4+ T cells, known to be involved in allograft tolerance, could be responsible, at least in part, for the success of pregnancy. In this review we focus the role effector CD4+ T cells Th1, Th2 and Th17 cells on the fetal allograft tolerance.
- 10 June 2015
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 13 (1) , 1-5
Open AccessT helper cell mediated-tolerance towards fetal allograft in successful pregnancy
Trophoblast HLA-C antigens from paternal origins, which liken the trophoblast to a semiallograft, could be presented by the maternal APCs to the specific maternal CD4+ T helper cells, which could release various cytokines in response to these alloantigens. On the basis of the cytokines produced, these cells can be classified in Th1, Th2 and Th17 cells. Th1 and Th17 cells, known to be responsible for acute allograft rejection, could be involved in miscarriage and Th2 cells together with regulatory CD4+ T cells, known to be involved in allograft tolerance, could be responsible, at least in part, for the success of pregnancy. In this review we focus the role effector CD4+ T cells Th1, Th2 and Th17 cells on the fetal allograft tolerance.
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 404
Human Decidual NK Cells: Unique and Tightly Regulated Effector Functions in Healthy and Pathogen-Infected Pregnancies
NK cells present in the peripheral blood (PB) respond rapidly to pathogens or pathogen-infected cells by various means including cytotoxicity and release of cytokines and chemokines. In addition they modulate adaptive immunity via the interaction with dendritic cells. Decidual NK cells (dNK) are poorly cytotoxic in healthy pregnancy, both in humans and rodents, when compared to their PB counterparts. We will discuss recent findings that may contribute to answer the following questions: i) Do dNK possess functional killing machinery in normal healthy pregnancy? ii) If so, what are the regulatory mechanisms that negatively control this effector function? iii) Have dNK from early pregnant uterus the intrinsic ability to kill pathogen-infected autologous maternal uterine cells and/or produce soluble factors that stimulate the anti-pathogen adaptive immune response? iv), Do dNK undergo a receptor repertoire profile shift when they are in contact with pathogen-infected uterine cells? v), Which pathogen-mediated signal(s) and molecular interactions subvert the inhibition of dNK cytolytic activity?
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 404
Open AccessHuman Decidual NK Cells: Unique and Tightly Regulated Effector Functions in Healthy and Pathogen-Infected Pregnancies
NK cells present in the peripheral blood (PB) respond rapidly to pathogens or pathogen-infected cells by various means including cytotoxicity and release of cytokines and chemokines. In addition they modulate adaptive immunity via the interaction with dendritic cells. Decidual NK cells (dNK) are poorly cytotoxic in healthy pregnancy, both in humans and rodents, when compared to their PB counterparts. We will discuss recent findings that may contribute to answer the following questions: i) Do dNK possess functional killing machinery in normal healthy pregnancy? ii) If so, what are the regulatory mechanisms that negatively control this effector function? iii) Have dNK from early pregnant uterus the intrinsic ability to kill pathogen-infected autologous maternal uterine cells and/or produce soluble factors that stimulate the anti-pathogen adaptive immune response? iv), Do dNK undergo a receptor repertoire profile shift when they are in contact with pathogen-infected uterine cells? v), Which pathogen-mediated signal(s) and molecular interactions subvert the inhibition of dNK cytolytic activity?
- Open Access
- 27 January 2012
- Published by EDP Sciences in médecine/sciences
- Vol. 28 (1) , 37-38
Nouvelle thérapie antiangiogénique indépendante du VEGF qui cible le récepteur CD160
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 27 January 2012
- Published by EDP Sciences in médecine/sciences
- Vol. 28 (1) , 37-38
Open AccessNouvelle thérapie antiangiogénique indépendante du VEGF qui cible le récepteur CD160
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 1 August 2011
- Published by Elsevier in Immunology Letters
- Vol. 138 (2) , 93-96
CD160: A unique activating NK cell receptor
- 1 August 2011
- Published by Elsevier in Immunology Letters
- Vol. 138 (2) , 93-96
CD160: A unique activating NK cell receptor
- Open Access
- 11 April 2011
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 208 (5) , 973-986
A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Angiogenesis plays an essential role in several diseases of the eye and in the growth of solid tumors, but existing antiangiogenic therapies have limited benefits in several cases. We report the antiangiogenic effects of a monoclonal antibody, CL1-R2, in several animal models of neovascularization. CL1-R2 recognizes human CD160, a membrane receptor which is conserved in various mammal species. We show that CD160 is expressed on the endothelial cells of newly formed blood vessels in human colon carcinoma and mouse B16 melanoma but not in vessels of healthy tissues. CL1-R2 reduced fibroblast growth factor 2–induced neovascularization in the rabbit cornea, in a mouse model of oxygen-induced retinopathy, and in a mouse Matrigel plug assay. Treatment of B16 melanoma-bearing mice with CL1-R2 combined with cyclophosphamide chemotherapy caused regression of the tumor vasculature and normalization of the remaining vessels as shown by Doppler ultrasonography, intravital microscopy, and histology. These studies validate CD160 as a potential new target in cases of human pathological ocular and tumor neoangiogenesis that do not respond or become resistant to existing antiangiogenic drugs.
- 11 April 2011
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 208 (5) , 973-986
Open AccessA novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor
Angiogenesis plays an essential role in several diseases of the eye and in the growth of solid tumors, but existing antiangiogenic therapies have limited benefits in several cases. We report the antiangiogenic effects of a monoclonal antibody, CL1-R2, in several animal models of neovascularization. CL1-R2 recognizes human CD160, a membrane receptor which is conserved in various mammal species. We show that CD160 is expressed on the endothelial cells of newly formed blood vessels in human colon carcinoma and mouse B16 melanoma but not in vessels of healthy tissues. CL1-R2 reduced fibroblast growth factor 2–induced neovascularization in the rabbit cornea, in a mouse model of oxygen-induced retinopathy, and in a mouse Matrigel plug assay. Treatment of B16 melanoma-bearing mice with CL1-R2 combined with cyclophosphamide chemotherapy caused regression of the tumor vasculature and normalization of the remaining vessels as shown by Doppler ultrasonography, intravital microscopy, and histology. These studies validate CD160 as a potential new target in cases of human pathological ocular and tumor neoangiogenesis that do not respond or become resistant to existing antiangiogenic drugs.
- 1 March 2011
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 88 (2) , 170-175
The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes?
- 1 March 2011
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 88 (2) , 170-175
The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes?